false
Catalog
Overcoming Barriers and Unlocking Clozapine: A Pan ...
Presentation Slides
Presentation Slides
Back to course
Pdf Summary
This document is a summary of a webinar on overcoming barriers and increasing the use of clozapine, a medication used in the treatment of serious mental illness. The webinar was part of the Clinical Support System for Serious Mental Illness (CSS-SMI) initiative, funded by the Substance Abuse and Mental Health Services Administration (SAMHSA) and implemented by the American Psychiatric Association (APA).<br /><br />The summary includes information on the objectives of the webinar, which are to list barriers to widespread clozapine adoption, evaluate the current literature on clozapine clinics, describe the advantages of using a clozapine clinic model, and discuss efforts to increase clozapine utilization.<br /><br />The summary also provides information on the current guidelines for prescribing clozapine and the variation in clozapine use across different states. It highlights the barriers to clozapine utilization, including client-related, prescriber-related, and administrative/logistical factors.<br /><br />Additionally, the summary discusses the advantages of clozapine clinics, such as supporting new starts, enhancing clinician familiarity and competency, and providing organized and specialized interventions. It also mentions the opportunities for systematic screening and treatment that clozapine clinics offer.<br /><br />The document includes experiences and perspectives from different institutions that have implemented clozapine clinics, including Northwell Zucker Hillside Hospital and the University of North Carolina. It concludes with information on how to claim continuing education credits for the webinar and details about an upcoming webinar on improving aftercare for people living with serious mental illness.
Keywords
Clozapine
Serious Mental Illness
Barriers
Clozapine Adoption
Clozapine Clinics
Clozapine Utilization
Prescribing Guidelines
State Variation
Client-related Factors
Clinician Familiarity
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
×
Please select your language
1
English